Haas E., Goldblatt H.Kinetic constants of the human renin and human angiotensinogen reaction . Circ Res1968; 20:45-55.
2.
Pickens PT, Bumpus FM, Lloyd AM et al. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation1994; 90:2207-12.
3.
Kurtz TW, Simonet L., Kabra PM,Wolfe S., Chan L., Hjelle BLCosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure. J Clin Invest1990;85(4):1328-32.
4.
Sun L., McArdle S., Chun M., Wolff DW, Pettinger WACosegregation of the renin gene with an increase in mean arterial blood pressure in the F2 rats of SHR-WKY cross. Clin Exp Hypertens1993;15(5):797-805.
5.
Naftilan AJ,Williams R., Burt D. et al. A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension. Hypertension1989;14(6):614-8.
6.
Soubrier F., Jeunemaitre X., Rigat B., Houot AM, Cambien F., Corvol P.Similar frequencies of renin gene restriction fragment length polymorphisms in hypertensive and normotensive subjects. Hypertension1990;16(6):712-7.
7.
Germain S., Bonnet F., Philippe J., Fuchs S., Corvol P., Pinet F.A novel distal enhancer confers chorionic expression on the human renin gene . J Biol Chem1998;273(39):25292-300.
8.
Kim HS, Krege JH, Kluckman KD et al. Genetic control of blood pressure and the angiotensinogen locus . Proc Natl Acad Sci USA1995;92(7):2735-9.
9.
Jeunemaitre X., Soubrier F., Kotelevtsev YV et al. Molecular basis of human hypertension: role of angiotensinogen. Cell1992 Oct 2;71(1):169-80.
10.
Iwai N., Shimoike H., Ohmichi N., Kinoshita M.Angiotensinogen gene and blood pressure in the Japanese population . Hypertension1995; 25:688-93.
11.
Arngrimsson R., Purandare S., Connor M. et al. Angiotensinogen: a candidate gene involved in preeclampsia?Nat Genet1993; 4:114-5.
12.
Jeunemaitre X., Inoue I., Williams C. et al. Haplotypes of angiotensinogen in essential hypertension. American Journal of Human Genetics1997; Jun; 60(6):1448-60.
13.
Neel JVThe genetics of diabetes mellitus. In Diabetes.Camerini .-Davalos R, Cole HS, editors. Academic. Press Inc., Orlando.Fl ; 1970;3-10.
14.
Brand E., Chatelain N., Keavney B. et al. Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension1998 Mar;31(3):725-9.
15.
HingoraniAD , Sharma P., Jia H., Hopper R., Brown MJBlood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension1996 Nov;28(5):907-11.
16.
Beige J., Zilch O., Hohenbleicher H. et al. Genetic variants of the renin-angiotensin system and ambulatory blood pressure in essential hypertension. Journal of Hypertension1997;15(5): 503-8.
17.
Caulfield M. , Lavender P., Farrall M. et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med1994 ;330(23):1629-33.
18.
Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F.An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest1990;86(4): 1343-6.
19.
Danser AH, Schalekamp MA, Bax WA et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation1995;92(6):1387-8. 20. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Soubrier F.An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. Am J Hum Genet1992; 51:197-205.
20.
Ueda S., Elliott HL, Morton JJ, Connell JMEnhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension1995;25(6):1266-9.
21.
Buikema H., Pinto YM, Rooks G., Grandjean JG, Schunkert H., van Gilst WHThe deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J1996;17(5):787-94.
22.
Perticone F. , Ceravolo R., Maio R. et al. Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension1998;31(4):900-5.
23.
Cambien F., Evans A.Angiotensin I converting enzyme gene polymorphism and coronary heart disease . Eur Heart J1995; 16 Suppl K:13-22.
24.
Ruiz J., Blanche H., Cohen N. et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA1994; 91(9):3662-5.
25.
Tiret L., Blanc H., Ruidavets JB et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Genes de l'Hypertension Arterielle Severe a moderee Essentielle. J Hypertens1998;16 (1):37-44.
26.
Lindpaintner K., Pfeffer MA, Kreutz R. et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med1995 ;332(11):706-11.
27.
Samani NJ,Thompson JR, O'Toole L., Channer K.,Woods KLA meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation1996;94(4):708-12.
28.
Keavney B., McKenzie C., Parish S. et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators . Lancet2000;355(9202):434-42.
29.
Schunkert H. , Hense HW, Holmer SR et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy . N Engl J Med1994 ;330(23):1634-8.
30.
Montgomery HE, Clarkson P., Dollery CM et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation1997;96(3):741-7.
31.
Kupari M., Perola M., Koskinen P., Virolainen J., Karhunen PJLeft ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol1994;267(3 Pt 2):H1107-H1111
32.
Lindpaintner K., Lee M., Larson MG et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. NEnglJMed1996;334 (16):1023-8.
33.
Raynolds MV , Perryman MBThe association between the angiotensin I converting enzyme gene polymorphism and cardiovascular disease. Coron Artery Dis1995;6(4):302-9.
34.
Busjahn A., Voss A., Knoblauch H. et al. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms and heart rate variability in twins. Am J Cardiol1998;81(6):755-60.
35.
Hilbert P., Lindpaintner K., Beckmann JS et al. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature1991;353(6344):521-9.
36.
Higashimori K., Zhao Y., Higaki J. et al. Association analysis of a polymorphism of the angiotensin-converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun1993;191(2):399-404.
37.
Jeunemaitre X., Lifton RP, Hunt SC, Williams RR, Lalouel JMAbsence of linkage between the angiotensin-converting enzyme locus and human essential hypertension . Nat Genet1992;1(1):72-5.
38.
Duru K., Farrow S., Wang JM, Lockette W., Kurtz T.Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens1994;7(8):759-62.
39.
O'Donnell CJ , Lindpaintner K., Larson MG et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation1998;97(18):1766-72.
40.
Julier C., Delepine M., Keavney B. et al. Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Human Molecular Genetics1997 Nov;6(12):2077-85.
41.
Levy D., DeStefano AL, Larson MG et al. Evidence for a gene influencing blood pressure on chromosome 17 : genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study. Hypertension2000;36(4):477-83.
42.
Krege JH, Kim HS, Moyer JS et al. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension1997;29(1 Pt 2):150-7.
43.
Griendling KK , Ushio-Fukai M., Lassegue B., Alexander RWAngiotensin II signaling in vascular smooth muscle. New concepts. Hypertension1997;29(1 Pt 2):366-73.
44.
Regitz-Zagrosek V., Neuss M., Holzmeister J., Warnecke C., Fleck E.Molecular biology of angiotensin receptors and their role in human cardiovascular disease. J Mol Med1996;74(5): 233-51.
45.
BonnardeauxA. , Davies E., Jeunemaitre X. et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension1994 Jul;24(1):63-9.
46.
Wang WY, Zee RY, Morris BJAssociation of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet1997;51(1):31-4.
47.
Schmidt S., Beige J.,Walla-Friedel M., Michel MC, SharmaAM, Ritz E.A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens1997;15(12 Pt 1):1385-8.
48.
Berge KE, Berg K.Polymorphisms at the angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) loci and normal blood pressure. Clin Genet1998;53(3):214-9.
49.
Tiret L., Bonnardeaux A., Poirier O. et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet1994;344:910-3.
50.
Berge KE, Bakken A., Bohn M., Erikssen J., Berg K.A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet1997;52(2):71-6.
51.
Benetos A., Gautier S., Ricard S. et al. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation1996;94(4):698-703.
52.
Benetos A., Cambien F., Gautier S. et al. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension1996; 28:1081-4.
53.
Castellano M., Muiesan ML, Beschi M. et al. Angiotensin II type 1 receptor A/C1166 polymorphism: relationship with blood pressure and cardiovascular structure . Hypertension1996 ; 28:1076-80.
54.
Miller JA,Thai K., Scholey JWAngiotensin II type 1 receptor polymorphism predicts response to losartan and angiotensin II. Kidney International1999 ; 56:2173-80.
55.
Lifton RP, Dluhy RG, Powers M. et al. A chimaeric 11 betahydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature1992; Jan 16;355(6357):262-5.
56.
Davies E., Holloway CD, Ingram MC et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2 . Hypertension1999;33(2):703-7.
57.
White PC, Slutsker L.Haplotype analysis of CYP11B2. Endocr Res1995;21(1-2):437-42.
58.
Kupari M., Hautanen A., Lankinen L. et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation1998;97(6):569-75.
59.
Ylitalo A.,Airaksinen KE, Hautanen A. et al. Baroreflex sensitivity and variants of the renin angiotensin system genes. J Am Coll Cardiol2000;35(1):194-200.
60.
Schunkert H. , Hengstenberg C., Holmer SR et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation1999; 99(17):2255-60.
61.
Pojoga L., Gautier S., Blanc H. et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens1998;11(7):856-60.
62.
Lim PO, Macdonald TM, Holloway C. et al. Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone to renin ratio- Annual Scientific Meeting of the British Hypertension Society, Cambridge, UK, 11-13 September 2000. J Hum Hypertens14(12), 837-856.